Medicine guide

GARDASIL

As listed in the register: GARDASIL 9

30 mcg + 40 mcg + 60 mcg + 40 mcg + 20 mcg + 20 mcg + 20 mcg + 20 mcg + 20 mcg · suspension

  • Prescription status not stated
  • Antibiotics, antivirals and antifungals taken into the body
Made by
Merck Canada Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupAntibiotics, antivirals and antifungals taken into the bodyJ07BM03

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byMerck Canada Inc
Active substanceRecombinant Human Papillomavirus Type 6 L1 Protein + Recombinant Human Papillomavirus Type 11 L1 Protein + Recombinant Human Papillomavirus Type 16 L1 Protein + Recombinant Human Papillomavirus Type 18 L1 Protein + Recombinant Human Papillomavirus Type 31 L1 Protein + Recombinant Human Papillomavirus Type 33 L1 Protein + Recombinant Human Papillomavirus Type 45 L1 Protein + Recombinant Human Papillomavirus Type 52 L1 Protein + Recombinant Human Papillomavirus Type 58 L1 Protein
Used inAntibiotics, antivirals and antifungals taken into the body
Strength30 mcg + 40 mcg + 60 mcg + 40 mcg + 20 mcg + 20 mcg + 20 mcg + 20 mcg + 20 mcg
Formsuspension
ClassificationJ07BM03 · Antibiotics, antivirals and antifungals taken into the body
Routeintramuscular
Dispensing (as stated by the register)SCHEDULE D
StatusMarketed
MarketedYes, according to the register
Name in the registerGARDASIL 9
DIN02437058
DPD drug code92136

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.